Albumin, WBC, RBC, Hemoglobin, Platelet, MCV and MCH levels in COVID-19 patients with Mucormycosis opportunistic infection

The coronavirus disease 19 (COVID-19) is a profoundly communicable and pathogenic viral disease brought about by intense respiratory disorder coronavirus 2, which made worldwide pandemic that drove a sensational loss of human existence around the world. Recently, instances of mucormycosis have been described in patients with Coronavirus. Routine laboratory tests especially biochemical and hematological are vital tests in terms of both finding and seriousness of Coronavirus. This study was intended to evaluate albumin, WBC, RBC, hemoglobin, platelet, MCV and MCH levels in COVID-19 patients suffering from mucormycosis. During this study, hospitalized COVID-19 patients with mucormycosis were investigated. Gender, age, hospitalization and recovery were patients recorded information. The laboratory parameters included albumin, WBC, RBC, hemoglobin, platelet, MCV and MCH levels. Finally, data was analyzed by SPSS. At present study, there was no significant difference between albumin, WBC, RBC, hemoglobin, platelet, MCV and MCH levels in COVID-19 patients suffering from mucormycosis levels based on gender, age, hospitalization and recovery parameters. According to results, it is essential to do more researches with a larger scale based on more parameters in patients with mucormycosis.